NCT05753618 2026-02-09
REaCT-OGF
Ottawa Hospital Research Institute
Phase 4 Recruiting
Clinical Trials
6 trialsNCT04781959 2025-03-21
A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy
Ottawa Hospital Research Institute
Phase 4 Completed
NCT02816112 2020-05-27
REaCT-TC2
Ottawa Hospital Research Institute
Phase 4 Completed
NCT02816164 2019-09-06
REaCT-G2
Ottawa Hospital Research Institute
Phase 4 Completed
NCT02805153 2016-06-20
PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Phase 4 Completed
NCT00030758 2013-08-07
Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer
National Cancer Institute (NCI)
Phase 4 Unknown